Latest filing published 07 Jun 2016 for SELLAS Life Sciences Group, Inc., €49k.
Insider track record
Ryan Dunlap: trading record in brief
Ryan Dunlap discloses dealings in SELLAS Life Sciences Group, Inc. to SEC (Form 4). We count 9 filings; the first trade dates from 31 December 2012 and the latest from 1 June 2016.
No open-market purchase appears, only 1 sale worth €247k. Besides market trades, the filings include 3 option exercises. 2016 to date brings no purchases and 1 sale.
The record was last updated on 7 June 2016 with an option exercise (€49k) in SELLAS Life Sciences Group, Inc. Typically, a trade is published a median of 6 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ryan Dunlap
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 31,250 shares@ US$1.7510.9% of flowCommon StockSEC:0001390478-16-000111:0
- 65,625 shares@ US$1.8524.1% of flowCommon StockSEC:0001390478-16-000111:1
- 30,000 shares@ US$1.7110.2% of flowCommon StockSEC:0001390478-16-000111:2
- 126,875 shares@ US$2.1854.9% of flowCommon StockSEC:0001390478-16-000111:3
- 3,846 shares@ US$1.28Common StockSEC:0001390478-15-000004:0
- 2,461 shares@ US$2.60Common StockSEC:0001390478-14-000030:0
- 2,728 shares@ US$1.88Common StockSEC:0001250853-14-000028:0
- 1,369 shares@ US$1.35Common Stock, par value $0.0001SEC:0001554742-13-000001:0
- 1,246 shares@ US$1.30Common Stock, par value $0.0001SEC:0001250853-13-000022:0
9 of 9 declarations